Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women.

Carlson, Robert W; Theriault, Richard; Schurman, Christine M; Rivera, Edgardo; Chung, Cathie T; Phan, See-Chun; Arun, Banu; Dice, Kristine; Chiv, Vivian Y; Green, Marjorie; Valero, Vicente

Carlson, Robert W; Theriault, Richard; Schurman, Christine M; Rivera, Edgardo; Chung, Cathie T; Phan, See-Chun; Arun, Banu; Dice, Kristine; Chiv, Vivian Y; Green, Marjorie; Valero, Vicente.

Affiliation

Carlson RW; Stanford Cancer Center, Stanford University, Stanford, CA 94305, USA. rcarlson@stanford.edu

J Clin Oncol ; 28(25): 3917-21, 2010 Sep 01.

Article in En | MEDLINE | ID: mdl-20679610

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Goserelin/administration & dosage; Neoplasms, Hormone-Dependent/drug therapy; Nitriles/administration & dosage; Triazoles/administration & dosage; Adult; Anastrozole; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Estradiol/metabolism; Female; Humans; Middle Aged; Neoplasm Metastasis; Premenopause

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triazoles / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Goserelin / Neoplasms, Hormone-Dependent / Nitriles Type of study: Clinical_trials Limits: Adult / Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2010 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google